These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2612004)

  • 1. A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus.
    Kortlandt W; Benschop C; Erkelens DW; Thijssen JH
    Clin Chim Acta; 1989 Dec; 186(1):109-17. PubMed ID: 2612004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus.
    Panteghini M; Cimino A; Pagani F; Girelli A
    Clin Biochem; 1995 Dec; 28(6):587-92. PubMed ID: 8595706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects.
    Tames FJ; Mackness MI; Arrol S; Laing I; Durrington PN
    Atherosclerosis; 1992 Apr; 93(3):237-44. PubMed ID: 1590828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of glycated apolipoprotein B in serum by a combination of affinity chromatography and immunonephelometry.
    Panteghini M; Bonora R; Pagani F
    Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():544-9. PubMed ID: 7880072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
    De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
    Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated apolipoprotein B-A surrogate marker of subclinical atherosclerosis.
    Dev K; Sharma SB; Garg S; Aggarwal A; Madhu SV
    Diabetes Metab Syndr; 2016; 10(2):78-81. PubMed ID: 26614298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved method for the quantitation of apolipoprotein B and apolipoprotein A-1 in dried blood spots.
    Wong N; Beeso J; Sherwood RA; Peters TJ
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():175-80. PubMed ID: 7785945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of non-enzymatically glycated apolipoprotein A1.
    Caines PS; Thibert RJ; Draisey TF; Foreback CC; Chu JW
    Clin Biochem; 1989 Aug; 22(4):285-7. PubMed ID: 2505947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated apolipoprotein A-I assay by combination of affinity chromatography and latex immunoagglutination.
    Shishino K; Murase M; Makino H; Saheki S
    Ann Clin Biochem; 2000 Jul; 37 ( Pt 4)():498-506. PubMed ID: 10902867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an increased glycation of IgG in diabetic patients.
    Danze PM; Tarjoman A; Rousseaux J; Fossati P; Dautrevaux M
    Clin Chim Acta; 1987 Jul; 166(2-3):143-53. PubMed ID: 3621595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo.
    Doucet C; Huby T; Ruiz J; Chapman MJ; Thillet J
    Atherosclerosis; 1995 Nov; 118(1):135-43. PubMed ID: 8579623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B.
    Brustolin D; Maierna M; Aguzzi F; Zoppi F; Tarenghi G; Berti G
    Clin Chem; 1991 May; 37(5):742-7. PubMed ID: 1903334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
    Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.
    Dean JD; Owens DR; Matthews SB
    Diabetes Res; 1990 Sep; 15(1):21-5. PubMed ID: 2132196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis.
    Quilliot D; Walters E; Guerci B; Fruchart JC; Duriez P; Drouin P; Ziegler O
    Metabolism; 2001 Sep; 50(9):1019-24. PubMed ID: 11555832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the measurement of serum fructosamine accurately reflect levels of glycated albumin in insulin-dependent diabetes?
    Winocour PH; Bhatnagar D; Reed P; Dhar H
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():47-52. PubMed ID: 3827184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis of human apolipoprotein B: effect on quantitative immunoturbidimetry.
    De Bruin TW; Vos MC; Kortlandt W; Bouma BN; Erkelens DW
    Clin Chim Acta; 1990 Dec; 193(3):137-45. PubMed ID: 2282692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The determination of apolipoproteins Apo A-I and Apo B. A comparative study of methods].
    Keller H; Riesen WF
    Z Med Lab Diagn; 1990; 31(4):200-10. PubMed ID: 2116698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein (a) concentrations in type 1 (insulin-dependent) diabetes mellitus.
    Serban V; Dabelea D; Deutsch G; Pataki C; Dan I
    Rom J Intern Med; 1995; 33(1-2):77-83. PubMed ID: 8535356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.